









市场行情
/
股票
/
nasdaq-flgt
/

Fulgent Genetics Inc

FLGT

26.360USD

+4.050+18.15%

收盘 11/07, 16:00（美东）报价延迟15分钟

813.31M总市值

亏损市盈率 TTM



Fulgent Genetics Inc

26.360

+4.050+18.15%

概览公司财务分析

概览

公司

财务

分析

关于 Fulgent Genetics Inc 公司

Fulgent Genetics, Inc. 是一家技术型基因公司，拥有实验室服务业务和治疗开发业务。该公司的实验室服务业务包括技术实验室服务和执业医师对实验室结果的专业解释。其治疗开发业务专注于使用纳米封装和靶向治疗平台开发用于治疗一系列癌症的候选药物，旨在改善新旧抗癌药物的治疗窗口和药代动力学 (PK) 特征。其实验室服务业务的技术平台包括基因探针、数据抑制和比较算法、学习软件和实验室信息管理系统。该平台提供测试菜单、快速开发和启动新测试的能力以及可定制的测试产品。该公司还提供下一代测序 (NGS) 服务。

Fulgent Genetics Inc简介



公司代码FLGT

公司名称Fulgent Genetics Inc

上市日期Sep 28, 2016

CEOMr. Ming Hsieh

员工数量1313

证券类型Ordinary Share

年结日Sep 28

公司地址4399 Santa Anita Ave

城市EL MONTE

上市交易所NASDAQ Global Market Consolidated

国家United States of America

邮编91731

电话16263500537

网址https://www.fulgentgenetics.com/

公司代码FLGT

上市日期Sep 28, 2016

CEOMr. Ming Hsieh

Fulgent Genetics Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Ming Hsieh

Chairman of the Board, Chief Executive Officer

8.76M

-0.07%

Dr. Hanlin (Harry) Gao, M.D., Ph.D.

Chief Scientific Officer, Laboratory Director

872.11K

-0.19%

Mr. Jian (James) Xie

President, Chief Operating Officer

236.22K

-1.81%

Mr. Paul Kim, CPA

Chief Financial Officer

231.60K

-1.17%

Ms. Linda Marsh

Independent Director

18.11K

+98.39%

Ms. Regina E. (Reggie) Groves

Independent Director

12.23K

+276.37%

Dr. Michael Nohaile, Ph.D.

Independent Director

10.51K

+74.68%

Ms. Melanie Solomon

Investor Relations

名称

名称/职务

职务

持股

持股变动

Mr. Ming Hsieh

Chairman of the Board, Chief Executive Officer

8.76M

-0.07%

Dr. Hanlin (Harry) Gao, M.D., Ph.D.

Chief Scientific Officer, Laboratory Director

872.11K

-0.19%

Mr. Jian (James) Xie

President, Chief Operating Officer

236.22K

-1.81%

Mr. Paul Kim, CPA

Chief Financial Officer

231.60K

-1.17%

Ms. Linda Marsh

Independent Director

18.11K

+98.39%

Ms. Regina E. (Reggie) Groves

Independent Director

12.23K

+276.37%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Institutional

45.62M

55.77%

Insurance

34.38M

42.03%

Patient

1.80M

2.20%

地区USD

名称

营收

占比

United States

76.21M

93.16%

Foreign

5.60M

6.84%

业务

地区

业务USD

名称

营收

占比

Institutional

45.62M

55.77%

Insurance

34.38M

42.03%

Patient

1.80M

2.20%

股东统计

更新时间: 11月8日周六

持股股东

股东类型

持股股东

占比

Hsieh (Ming)

28.34%

BlackRock Institutional Trust Company, N.A.

5.25%

Millennium Management LLC

4.67%

The Vanguard Group, Inc.

3.80%

Dimensional Fund Advisors, L.P.

3.67%

其他

54.28%

持股股东

占比

Hsieh (Ming)

28.34%

BlackRock Institutional Trust Company, N.A.

5.25%

Millennium Management LLC

4.67%

The Vanguard Group, Inc.

3.80%

Dimensional Fund Advisors, L.P.

3.67%

其他

54.28%

股东类型

持股股东

占比

Individual Investor

33.14%

Investment Advisor/Hedge Fund

18.70%

Investment Advisor

18.67%

Hedge Fund

14.00%

Research Firm

1.99%

Pension Fund

0.49%

Bank and Trust

0.36%

Venture Capital

0.05%

Insurance Company

0.02%

其他

12.58%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

439

16.89M

55.17%

-1.14M

2025Q2

464

27.21M

89.02%

-3.13M

2025Q1

479

26.79M

87.53%

-3.17M

2024Q4

478

27.37M

89.05%

-1.51M

2024Q3

495

26.29M

86.76%

-1.76M

2024Q2

531

25.43M

84.95%

-2.34M

2024Q1

552

25.03M

83.71%

-1.71M

2023Q4

583

24.11M

81.35%

-2.57M

2023Q3

588

24.06M

80.39%

-2.54M

2023Q2

592

23.63M

79.58%

-3.71M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Hsieh (Ming)

8.76M

28.62%

-6.40K

-0.07%

Aug 26, 2025

BlackRock Institutional Trust Company, N.A.

1.62M

5.3%

-69.12K

-4.09%

Jun 30, 2025

Millennium Management LLC

1.44M

4.71%

Jul 29, 2025

The Vanguard Group, Inc.

1.16M

3.79%

-4.25K

-0.37%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

1.13M

3.71%

+105.42K

+10.25%

Jun 30, 2025

Acadian Asset Management LLC

1.12M

3.65%

+311.98K

+38.71%

Jun 30, 2025

Gao (Hanlin)

873.75K

2.85%

-1.06K

-0.12%

Sep 03, 2025

Citadel Advisors LLC

603.65K

1.97%

+167.91K

+38.53%

Jun 30, 2025

Point72 Asset Management, L.P.

544.88K

1.78%

+508.69K

+1405.81%

Jun 30, 2025

State Street Investment Management (US)

513.80K

1.68%

+7.01K

+1.38%

Jun 30, 2025

持股ETF



更新时间: 11月6日周四

机构名称

占比

SPDR S&P Health Care Services ETF

0.68%

Global X Genomics & Biotechnology ETF

0.52%

iShares US Small Cap Value Factor ETF

0.41%

ALPS Medical Breakthroughs ETF

0.41%

iShares MSCI USA Small-Cap Min Vol Factor ETF

0.08%

iShares U.S. Healthcare Providers ETF

0.07%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.06%

Avantis US Small Cap Equity ETF

0.06%

Goldman Sachs Innovate Equity ETF

0.05%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.05%

SPDR S&P Health Care Services ETF

占比0.68%

Global X Genomics & Biotechnology ETF

占比0.52%

iShares US Small Cap Value Factor ETF

占比0.41%

ALPS Medical Breakthroughs ETF

占比0.41%

iShares MSCI USA Small-Cap Min Vol Factor ETF

占比0.08%

iShares U.S. Healthcare Providers ETF

占比0.07%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

占比0.06%

Avantis US Small Cap Equity ETF

占比0.06%

Goldman Sachs Innovate Equity ETF

占比0.05%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

占比0.05%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

KeyAI

